Acquiring Company
Viatris
Acquired Company
Capra Biosciences, Inc
Description
Viatris Inc. has completed its acquisition of Pacira BioSciences, Inc. through a tender offer at $36.50 per share in cash, followed by a merger under Delaware law. Pacira is now a wholly owned subsidiary of Viatris and its shares will be delisted from the Nasdaq Global Select Market. Viatris expects the acquisition to contribute total revenues of between $90 million and $100 million for the remainder of 2026.
Quick answer
Viatris is acquiring Capra Biosciences, Inc, announced November 17, 2026. Viatris is based in Canonsburg, Pennsylvania, United States.
- How much did Viatris pay for Capra Biosciences, Inc?
- The deal value was not disclosed.
- What does Viatris do?
- Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania.
- Where are Viatris and Capra Biosciences, Inc based?
- Viatris is based in Canonsburg, Pennsylvania, United States. Capra Biosciences, Inc is based in Alexandria, Virginia, United States.
Source: Fundz verified event record.
Other recent acquisitions in Medical Device and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Everis Medical combines with Hemostasis (November 17, 2026)
- AddLife acquires Portuguese distributor MoonSurge (November 2, 2026)
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- Bedfont® acquires coVita™ to enhance US presence (October 13, 2026)
- Medneo UK to acquire Burgess Diagnostics (October 9, 2026)
- Nelipak acquires Technipaq for healthcare packaging (November 11, 2026)
Who to call at Viatris, and when
When Viatris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Viatris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viatris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viatris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Capra Biosciences, Inc?
Capra Biosciences, Inc was acquired by Viatris, based in Canonsburg. The deal was reported on November 17, 2026. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).
When did Viatris acquire Capra Biosciences, Inc?
Viatris's acquisition of Capra Biosciences, Inc was reported on November 17, 2026. Viatris Inc. has completed its acquisition of Pacira BioSciences, Inc. through a tender offer at $36.50 per share in cash, followed by a merger under Delaware law. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Capra Biosciences, Inc do?
Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in Alexandria.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.